IndraLab

Statements

DRB activates PRPF8. 1 / 1

| 1

reach

"Briefly, control siRNA treated cells and PRPF8 depleted cells were treated with DRB (5,6-dichlorobenzimidazole 1-beta-D-ribofuranoside), a reversible inhibitor of transcriptional elongation [XREF_BIBR]."

26392272

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

DRB activates PRPF8. 1 / 1

INDRA sources:

Databases

Reading